Clinical pregnancy outcomes with assisted reproduction in patients with 17α-Hydroxylase/17, 20-lyase deficiency: a single center cohort study and integrated analysis with reported cases - Summary - MDSpire

Clinical pregnancy outcomes with assisted reproduction in patients with 17α-Hydroxylase/17, 20-lyase deficiency: a single center cohort study and integrated analysis with reported cases

  • By

  • Ye Liu

  • Chunmei Zhang

  • Ran Lu

  • Rong Li

  • Ying Wang

  • Haining Wang

  • June 29, 2026

  • 0 min

Share

Objective:

To report assisted reproductive courses and outcomes in women with 17α-hydroxylase/17, 20-lyase deficiency (17OHD) and to summarize management strategies.

Approach:
  • Study Design: Retrospective cohort study of women with 17OHD who achieved clinical pregnancy at a tertiary center from January 2009 to August 2025, along with a systematic review of published cases.
  • Participants: Included female patients diagnosed with 17OHD, confirmed by clinical presentation and genetic testing, who desired fertility.
  • Data Collection: Demographic, clinical, laboratory, treatment, and outcome data were extracted and analyzed.
Key Findings:
  • Among 20 female patients with 17OHD at our center, six desired fertility and three achieved clinical pregnancy with ART.
  • Combined with 17 reported cases from 12 studies, a total of 20 pregnancies resulted in 23 live births.
  • Median age at pregnancy preparation was 29 (range 21–42) years.
  • The prevalence rates of hypertension and adrenal insufficiency were 25.0% (5/20) and 50.0% (10/20), respectively.
  • Pregnancy complications occurred in 46.2% (6/13) cases, and only 25% (5/20) had term vaginal deliveries.
Interpretation:

Limitations:
  • Small sample size and retrospective design limit generalizability.
  • Long-term health outcomes for mothers and children remain unclear.
Conclusion:

Original Source(s)

Related Content